메뉴 건너뛰기




Volumn 38, Issue 10, 2008, Pages 1026-1039

Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-β1 in a cultured stellate cell line

Author keywords

Bezafibrate; Hepatic fibrosis; Hepatic stellate cell activation; Methionine and choline deficient diet; Non alcoholic steatohepatitis; Peroxisome proliferator activated receptors

Indexed keywords

[2 METHYL 4 [4 METHYL 2 (4 TRIFLUOROMETHYLPHENYL) 5 THIAZOLYLMETHYLTHIO]PHENOXY]ACETIC ACID; ADIPONECTIN; ALANINE AMINOTRANSFERASE; BEZAFIBRATE; CHEMOKINE; CHOLINE; CYTOKINE; FENOFIBRIC ACID; MESSENGER RNA; METHIONINE; PIOGLITAZONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRANSFORMING GROWTH FACTOR BETA1; TRIACYLGLYCEROL;

EID: 51349140361     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00363.x     Document Type: Article
Times cited : (38)

References (55)
  • 1
    • 0032771475 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis
    • Diehl AM. Nonalcoholic steatohepatitis. Semin Liver Dis 1999; 19: 221-9.
    • (1999) Semin Liver Dis , vol.19 , pp. 221-229
    • Diehl, A.M.1
  • 2
    • 0037382786 scopus 로고    scopus 로고
    • Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
    • Marchesini G, Bugianesi E, Forlani G et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003; 37: 917-23.
    • (2003) Hepatology , vol.37 , pp. 917-923
    • Marchesini, G.1    Bugianesi, E.2    Forlani, G.3
  • 3
    • 18244385511 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association
    • Pagano G, Pacini G, Musso G et al. Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic association. Hepatology 2002; 35: 367-72.
    • (2002) Hepatology , vol.35 , pp. 367-372
    • Pagano, G.1    Pacini, G.2    Musso, G.3
  • 4
    • 0031947715 scopus 로고    scopus 로고
    • Steatohepatitis: A tale of two "hits"?
    • Day CP, James OF. Steatohepatitis: A tale of two "hits"? Gastroenterology 1998; 114: 842-5.
    • (1998) Gastroenterology , vol.114 , pp. 842-845
    • Day, C.P.1    James, O.F.2
  • 5
    • 0038644536 scopus 로고    scopus 로고
    • Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference
    • Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003; 37: 1202-19.
    • (2003) Hepatology , vol.37 , pp. 1202-1219
    • Neuschwander-Tetri, B.A.1    Caldwell, S.H.2
  • 6
    • 0032211577 scopus 로고    scopus 로고
    • Molecular regulation of hepatic fibrogenesis
    • Olaso E, Friedman SL. Molecular regulation of hepatic fibrogenesis. J Hepatol 1998; 29: 836-47.
    • (1998) J Hepatol , vol.29 , pp. 836-847
    • Olaso, E.1    Friedman, S.L.2
  • 7
    • 33746521801 scopus 로고
    • Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies
    • Friedman SL. Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-35.
    • (1993) N Engl J Med , vol.328 , pp. 1828-1835
    • Friedman, S.L.1
  • 8
    • 0025000652 scopus 로고
    • Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo
    • Maher JJ, McGuire RF. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo. J Clin Invest 1990; 86: 1641-8.
    • (1990) J Clin Invest , vol.86 , pp. 1641-1648
    • Maher, J.J.1    McGuire, R.F.2
  • 9
    • 0026519114 scopus 로고
    • Lipocyte activation and hepatic fibrosis
    • Bissell DM. Lipocyte activation and hepatic fibrosis. Gastroenterology 1992; 102: 1803-5.
    • (1992) Gastroenterology , vol.102 , pp. 1803-1805
    • Bissell, D.M.1
  • 11
    • 27344454809 scopus 로고    scopus 로고
    • Transgenic expression of mutant peroxisome proliferator-activated receptor γ in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice
    • Tanaka T, Masuzaki H, Ebihara K et al. Transgenic expression of mutant peroxisome proliferator-activated receptor γ in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice. Metabolism 2005; 54: 1490-8.
    • (2005) Metabolism , vol.54 , pp. 1490-1498
    • Tanaka, T.1    Masuzaki, H.2    Ebihara, K.3
  • 12
    • 0037385387 scopus 로고    scopus 로고
    • Interim results of a pilot study demonstrating the early effects of the PPAR-γ ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis
    • Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Sponseller CA, Hampton K, Bacon BR. Interim results of a pilot study demonstrating the early effects of the PPAR-γ ligand rosiglitazone on insulin sensitivity, aminotransferases, hepatic steatosis and body weight in patients with non-alcoholic steatohepatitis. J Hepatol 2003; 38: 434-40.
    • (2003) J Hepatol , vol.38 , pp. 434-440
    • Neuschwander-Tetri, B.A.1    Brunt, E.M.2    Wehmeier, K.R.3    Sponseller, C.A.4    Hampton, K.5    Bacon, B.R.6
  • 13
    • 0141532275 scopus 로고    scopus 로고
    • Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone
    • Neuschwander-Tetri BA, Brunt EM, Wehmeier KR, Oliver D, Bacon BR. Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone. Hepatology 2003; 38: 1008-17.
    • (2003) Hepatology , vol.38 , pp. 1008-1017
    • Neuschwander-Tetri, B.A.1    Brunt, E.M.2    Wehmeier, K.R.3    Oliver, D.4    Bacon, B.R.5
  • 14
    • 0033962940 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells
    • Galli A, Crabb D, Price D et al. Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. Hepatology 2000; 31: 101-8.
    • (2000) Hepatology , vol.31 , pp. 101-108
    • Galli, A.1    Crabb, D.2    Price, D.3
  • 15
    • 0033855572 scopus 로고    scopus 로고
    • Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells
    • Marra F, Efsen E, Romanelli RG et al. Ligands of peroxisome proliferator-activated receptor γ modulate profibrogenic and proinflammatory actions in hepatic stellate cells. Gastroenterology 2000; 119: 466-78.
    • (2000) Gastroenterology , vol.119 , pp. 466-478
    • Marra, F.1    Efsen, E.2    Romanelli, R.G.3
  • 16
    • 0036086754 scopus 로고    scopus 로고
    • Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride
    • Kon K, Ikejima K, Hirose M et al. Pioglitazone prevents early-phase hepatic fibrogenesis caused by carbon tetrachloride. Biochem Biophys Res Commun 2002; 291: 55-61.
    • (2002) Biochem Biophys Res Commun , vol.291 , pp. 55-61
    • Kon, K.1    Ikejima, K.2    Hirose, M.3
  • 17
    • 0036082703 scopus 로고    scopus 로고
    • Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro
    • Galli A, Crabb DW, Ceni E et al. Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro. Gastroenterology 2002; 122: 1924-40.
    • (2002) Gastroenterology , vol.122 , pp. 1924-1940
    • Galli, A.1    Crabb, D.W.2    Ceni, E.3
  • 19
    • 2442660528 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease
    • Tenenbaum A, Motro M, Fisman EZ et al. Peroxisome proliferator-activated receptor ligand bezafibrate for prevention of type 2 diabetes mellitus in patients with coronary artery disease. Circulation 2004; 109: 2197-202.
    • (2004) Circulation , vol.109 , pp. 2197-2202
    • Tenenbaum, A.1    Motro, M.2    Fisman, E.Z.3
  • 20
    • 33645738300 scopus 로고    scopus 로고
    • Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate
    • Tenenbaum A, Fisman EZ, Boyko V et al. Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate. Arch Intern Med 2006; 166: 737-41.
    • (2006) Arch Intern Med , vol.166 , pp. 737-741
    • Tenenbaum, A.1    Fisman, E.Z.2    Boyko, V.3
  • 21
    • 0033594768 scopus 로고    scopus 로고
    • Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis
    • Saibara T, Onishi S, Ogawa Y, Yoshida S, Enzan H. Bezafibrate for tamoxifen-induced non-alcoholic steatohepatitis. Lancet 1999; 353: 1802.
    • (1999) Lancet , vol.353 , pp. 1802
    • Saibara, T.1    Onishi, S.2    Ogawa, Y.3    Yoshida, S.4    Enzan, H.5
  • 22
    • 5144224821 scopus 로고    scopus 로고
    • PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats
    • Toyama T, Nakamura H, Harano Y et al. PPARα ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats. Biochem Biophys Res Commun 2004; 324: 697-704.
    • (2004) Biochem Biophys Res Commun , vol.324 , pp. 697-704
    • Toyama, T.1    Nakamura, H.2    Harano, Y.3
  • 23
    • 2342644813 scopus 로고    scopus 로고
    • Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice
    • Ip E, Farrell G, Hall P, Robertson G, Leclercq I etal. Administration of the potent PPARα agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice. Hepatology 2004; 39: 1286-96.
    • (2004) Hepatology , vol.39 , pp. 1286-1296
    • Ip, E.1    Farrell, G.2    Hall, P.3    Robertson, G.4    Leclercq, I.5
  • 24
    • 0242438087 scopus 로고    scopus 로고
    • Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis
    • George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. J Hepatol 2003; 39: 756-64.
    • (2003) J Hepatol , vol.39 , pp. 756-764
    • George, J.1    Pera, N.2    Phung, N.3    Leclercq, I.4    Yun Hou, J.5    Farrell, G.6
  • 25
    • 0038643427 scopus 로고    scopus 로고
    • Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice
    • Ip E, Farrell GC, Robertson G, Hall P, Kirsch R, Leclercq I. Central role of PPARα-dependent hepatic lipid turnover in dietary steatohepatitis in mice. Hepatology 2003; 38: 123-32.
    • (2003) Hepatology , vol.38 , pp. 123-132
    • Ip, E.1    Farrell, G.C.2    Robertson, G.3    Hall, P.4    Kirsch, R.5    Leclercq, I.6
  • 28
    • 0029829455 scopus 로고    scopus 로고
    • Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation
    • Weltman MD, Farrell GC, Liddle C. Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 1996; 111: 1645-53.
    • (1996) Gastroenterology , vol.111 , pp. 1645-1653
    • Weltman, M.D.1    Farrell, G.C.2    Liddle, C.3
  • 29
    • 70449158340 scopus 로고
    • A simple method for the isolation and purification of total lipids from animal tissues
    • Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
    • (1957) J Biol Chem , vol.226 , pp. 497-509
    • Folch, J.1    Lees, M.2    Stanley, G.H.S.3
  • 30
    • 0033043662 scopus 로고    scopus 로고
    • SV40 large T antigen immortalization of rat hepatic stellate-like cells
    • Tokiwa T, Yata Y, Takahara T et al. SV40 large T antigen immortalization of rat hepatic stellate-like cells. In Vitro Cell Dev Biol Anim 1999; 35: 246-7.
    • (1999) In Vitro Cell Dev Biol Anim , vol.35 , pp. 246-247
    • Tokiwa, T.1    Yata, Y.2    Takahara, T.3
  • 31
    • 0032955139 scopus 로고    scopus 로고
    • Characterization of immortalized rat hepatic stellate cell lines transfected with SV40 T antigen
    • Yutaka Y, Tokiwa T, Takahara T, Zhang LP, Watanabe A. Characterization of immortalized rat hepatic stellate cell lines transfected with SV40 T antigen. Hepatol Res 1999; 14: 239-44.
    • (1999) Hepatol Res , vol.14 , pp. 239-244
    • Yutaka, Y.1    Tokiwa, T.2    Takahara, T.3    Zhang, L.P.4    Watanabe, A.5
  • 32
    • 33645891166 scopus 로고    scopus 로고
    • Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARä agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet
    • Nagasawa T, Inada Y, Nakano S et al. Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARä agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet. Eur J Pharmacol 2006; 536: 182-91.
    • (2006) Eur J Pharmacol , vol.536 , pp. 182-191
    • Nagasawa, T.1    Inada, Y.2    Nakano, S.3
  • 33
    • 0038823617 scopus 로고    scopus 로고
    • Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation
    • Chavey C, Mari B, Monthouel MN et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003; 278: 11888-96.
    • (2003) J Biol Chem , vol.278 , pp. 11888-11896
    • Chavey, C.1    Mari, B.2    Monthouel, M.N.3
  • 34
    • 19544378172 scopus 로고    scopus 로고
    • The roles of leptin and adiponectin: A novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology
    • Ding X, Saxena NK, Lin S, Xu A, Srinivasan S, Anania FA. The roles of leptin and adiponectin: A novel paradigm in adipocytokine regulation of liver fibrosis and stellate cell biology. Am J Pathol 2005; 166: 1655-69.
    • (2005) Am J Pathol , vol.166 , pp. 1655-1669
    • Ding, X.1    Saxena, N.K.2    Lin, S.3    Xu, A.4    Srinivasan, S.5    Anania, F.A.6
  • 35
    • 0141765849 scopus 로고    scopus 로고
    • Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia
    • Kuzuya M, Kanda S, Sasaki T et al. Deficiency of gelatinase a suppresses smooth muscle cell invasion and development of experimental intimal hyperplasia. Circulation 2003; 108: 1375-81.
    • (2003) Circulation , vol.108 , pp. 1375-1381
    • Kuzuya, M.1    Kanda, S.2    Sasaki, T.3
  • 36
    • 0037133240 scopus 로고    scopus 로고
    • Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice
    • Trogan E, Choudhury RP, Dansky HM, Rong JX, Breslow JL, Fisher EA. Laser capture microdissection analysis of gene expression in macrophages from atherosclerotic lesions of apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 2003; 99: 2234-9.
    • (2003) Proc Natl Acad Sci USA , vol.99 , pp. 2234-2239
    • Trogan, E.1    Choudhury, R.P.2    Dansky, H.M.3    Rong, J.X.4    Breslow, J.L.5    Fisher, E.A.6
  • 37
    • 0029922002 scopus 로고    scopus 로고
    • Fibrates induce mdr2 gene expression and biliary phospholipids secretion in the mouse
    • Chianale J, Vollrath V, Wielandt AM et al. Fibrates induce mdr2 gene expression and biliary phospholipids secretion in the mouse. Biochem J 1996; 314: 781-6.
    • (1996) Biochem J , vol.314 , pp. 781-786
    • Chianale, J.1    Vollrath, V.2    Wielandt, A.M.3
  • 38
    • 0038694566 scopus 로고    scopus 로고
    • Bezafibrate is a dual ligand for PPARα and PPARβ: Studies using null mice
    • Peters JM, Aoyama T, Burns AM, Gonzalez FJ. Bezafibrate is a dual ligand for PPARα and PPARβ: Studies using null mice. Biochim Biophys Acta 2003; 1632: 80-9.
    • (2003) Biochim Biophys Acta , vol.1632 , pp. 80-89
    • Peters, J.M.1    Aoyama, T.2    Burns, A.M.3    Gonzalez, F.J.4
  • 39
    • 24144496798 scopus 로고    scopus 로고
    • Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of,-cell differentiation and secretory function in the db/ db mouse model of diabetes
    • Kjorholt C, Akerfeldt MC, Biden TJ, Laybutt DR. Chronic hyperglycemia, independent of plasma lipid levels, is sufficient for the loss of,-cell differentiation and secretory function in the db/db mouse model of diabetes. Diabetes 2005; 54: 2755-63.
    • (2005) Diabetes , vol.54 , pp. 2755-2763
    • Kjorholt, C.1    Akerfeldt, M.C.2    Biden, T.J.3    Laybutt, D.R.4
  • 40
    • 34249908931 scopus 로고    scopus 로고
    • Bezafibrate induces multidrug-resistance P-Glycoprotein 3 expression in cultured human hepatocytes and humanized livers of chimeric mice
    • Shoda J, Okada K, Inada Y et al. Bezafibrate induces multidrug-resistance P-Glycoprotein 3 expression in cultured human hepatocytes and humanized livers of chimeric mice. Hepatol Res 2007; 37: 548-56.
    • (2007) Hepatol Res , vol.37 , pp. 548-556
    • Shoda, J.1    Okada, K.2    Inada, Y.3
  • 41
    • 16644368576 scopus 로고    scopus 로고
    • Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARα-mediated redistribution of ABCB4
    • Shoda J, Inada Y, Tsuji A et al. Bezafibrate stimulates canalicular localization of NBD-labeled PC in HepG2 cells by PPARα-mediated redistribution of ABCB4. J Lipid Res 2004; 45: 1813-25.
    • (2004) J Lipid Res , vol.45 , pp. 1813-1825
    • Shoda, J.1    Inada, Y.2    Tsuji, A.3
  • 42
    • 0032479423 scopus 로고    scopus 로고
    • Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N. Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue- and inducer-specific manner. J Biol Chem 1998; 273: 16710-14.
    • (1998) J Biol Chem , vol.273 , pp. 16710-16714
    • Motojima, K.1    Passilly, P.2    Peters, J.M.3    Gonzalez, F.J.4    Latruffe, N.5
  • 43
    • 0033061409 scopus 로고    scopus 로고
    • Increased peroxisomal fatty acid,-oxidation and enhanced expression of peroxisome proliferator-activated receptor-α in diabetic rat liver
    • Asayama K, Sandhir R, Sheikh FG, Hayashibe H, Nakane T, Singh I. Increased peroxisomal fatty acid,-oxidation and enhanced expression of peroxisome proliferator-activated receptor-α in diabetic rat liver. Mol Cell Biochem 1999; 194: 227-34.
    • (1999) Mol Cell Biochem , vol.194 , pp. 227-234
    • Asayama, K.1    Sandhir, R.2    Sheikh, F.G.3    Hayashibe, H.4    Nakane, T.5    Singh, I.6
  • 44
    • 0034711185 scopus 로고    scopus 로고
    • Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators
    • Delerive P, Gervois P, Fruchart JC, Staels B. Induction of IκBα expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-α activators. J Biol Chem 2000; 275: 36703-7.
    • (2000) J Biol Chem , vol.275 , pp. 36703-36707
    • Delerive, P.1    Gervois, P.2    Fruchart, J.C.3    Staels, B.4
  • 45
    • 36148934819 scopus 로고    scopus 로고
    • Life style-related diseases of the digestive system: Gene expression in nonalcoholic steatohepatitis patients and treatment strategies
    • Yoneda M, Endo H, Nozaki Y et al. Life style-related diseases of the digestive system: Gene expression in nonalcoholic steatohepatitis patients and treatment strategies. J Pharmacol Sci 2007; 105: 151-6.
    • (2007) J Pharmacol Sci , vol.105 , pp. 151-156
    • Yoneda, M.1    Endo, H.2    Nozaki, Y.3
  • 46
    • 34047199047 scopus 로고    scopus 로고
    • Bezafibrate regulates the expression and enzyme activity of 11β-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes
    • Nakano S, Inada Y, Masuzaki H et al. Bezafibrate regulates the expression and enzyme activity of 11β-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2007; 292: E1213-22.
    • (2007) Am J Physiol Endocrinol Metab , vol.292
    • Nakano, S.1    Inada, Y.2    Masuzaki, H.3
  • 47
    • 3042820278 scopus 로고    scopus 로고
    • Liver injury in the setting of steatosis: Crosstalk between adipokine and cytokine
    • Czaja MJ. Liver injury in the setting of steatosis: Crosstalk between adipokine and cytokine. Hepatology 2004; 40: 19-22.
    • (2004) Hepatology , vol.40 , pp. 19-22
    • Czaja, M.J.1
  • 48
    • 10744228583 scopus 로고    scopus 로고
    • Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
    • Kamada Y, Tamura S, Kiso S et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 2003; 125: 1796-807.
    • (2003) Gastroenterology , vol.125 , pp. 1796-1807
    • Kamada, Y.1    Tamura, S.2    Kiso, S.3
  • 49
    • 0037221210 scopus 로고    scopus 로고
    • Peroxisome proliferator-activated receptor-β signaling contributes to enhanced proliferation of hepatic stellate cells
    • Hellemans K, Michalik L, Dittie A et al. Peroxisome proliferator-activated receptor-β signaling contributes to enhanced proliferation of hepatic stellate cells. Gastroenterology 2003; 124: 184-201.
    • (2003) Gastroenterology , vol.124 , pp. 184-201
    • Hellemans, K.1    Michalik, L.2    Dittie, A.3
  • 50
    • 33845788135 scopus 로고    scopus 로고
    • Intrahepatic insulin resistance in a murine model of steatohepa titis: Effect of PPARγ agonist pioglitazone
    • Leclercq IA, Lebrun VA, Starkel P, Horsmans YJ. Intrahepatic insulin resistance in a murine model of steatohepa titis: Effect of PPARγ agonist pioglitazone. Lab Invest 2007; 87: 56-65.
    • (2007) Lab Invest , vol.87 , pp. 56-65
    • Leclercq, I.A.1    Lebrun, V.A.2    Starkel, P.3    Horsmans, Y.J.4
  • 51
    • 33846253661 scopus 로고    scopus 로고
    • Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis
    • Ota T, Takamura T, Kurita S et al. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis. Gastroenterology 2007; 132: 282-93.
    • (2007) Gastroenterology , vol.132 , pp. 282-293
    • Ota, T.1    Takamura, T.2    Kurita, S.3
  • 52
    • 0842308111 scopus 로고    scopus 로고
    • Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient 1-amino acid-defined diet
    • Kawaguchi K, Sakaida I, Tsuchiya M, Omori K, Takami T, Okita K. Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient 1-amino acid-defined diet. Biochem Biophys Res Commun 2004; 315: 187-95.
    • (2004) Biochem Biophys Res Commun , vol.315 , pp. 187-195
    • Kawaguchi, K.1    Sakaida, I.2    Tsuchiya, M.3    Omori, K.4    Takami, T.5    Okita, K.6
  • 53
    • 23944486588 scopus 로고    scopus 로고
    • The peroxisome proliferator-activated receptor-γ agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, 1-amino acid-defined diet
    • Uto H, Nakanishi C, Ido A et al. The peroxisome proliferator-activated receptor-γ agonist, pioglitazone, inhibits fat accumulation and fibrosis in the livers of rats fed a choline-deficient, 1-amino acid-defined diet. Hepatol Res 2005; 32: 235-42.
    • (2005) Hepatol Res , vol.32 , pp. 235-242
    • Uto, H.1    Nakanishi, C.2    Ido, A.3
  • 54
    • 0034743328 scopus 로고    scopus 로고
    • y mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones
    • y mice exhibit increased hepatic PPARγ1 gene expression and develop hepatic steatosis upon chronic treatment with antidiabetic thiazolidinediones. J Hepatol 2001; 35: 17-23.
    • (2001) J Hepatol , vol.35 , pp. 17-23
    • Bedoucha, M.1    Atzpodien, E.2    Boelsterli, U.A.3
  • 55
    • 0346689994 scopus 로고    scopus 로고
    • The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance
    • Rinella ME, Green RM. The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance. J Hepatol 2004; 40: 47-51.
    • (2004) J Hepatol , vol.40 , pp. 47-51
    • Rinella, M.E.1    Green, R.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.